Life Sciences
2 stories
-
techOpenAI Unveils GPT-Rosalind for Life Sciences Breakthroughs
OpenAI introduces GPT-Rosalind, an AI model designed to accelerate research in biology, drug discovery, and medicine by enhancing scientific workflows and reasoning.
-
techDassault Systèmes Pivots to AI Pricing Model Amid Stock Sell-Off
CEO Pascal Daloz shifts Dassault Systèmes to outcome-based AI pricing. Shares fall on revenue miss, but long-term strategy targets virtual twins and life sciences growth.